CytoNiche’s Intelligent 3D FloTrix® Technology Powers Approval of China’s First Stem Cell Drug
2025-01-03
(Summary description)In 2018, the technology was successfully translated into Beijing CytoNiche Biotechnology Co., Ltd., joined by Tsinghua University equity-wise.
(Summary description)In 2018, the technology was successfully translated into Beijing CytoNiche Biotechnology Co., Ltd., joined by Tsinghua University equity-wise.
In 2018, the technology was successfully translated into Beijing CytoNiche Biotechnology Co., Ltd., joined by Tsinghua University equity-wise.
Scan the QR code to read on your phone